06.02.2023 11:15
Founded in the US and operationally headquartered in Zürich, cellvie is developing medicines from cells, leveraging the therapeutic potential of mitochondria, commonly known as the powerhouses of the cell. The fresh capital will be employed to accelerate the development of the company’s technology platform, strengthen the team, and further establish mitochondria manufacturing.